Anemia  >>  cyclosporine 
Welcome,         Profile    Billing    Logout  

24 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
ChiCTR2100044033: A prospective randomized controlled trial of the clinical program of different doses of antithymoglobulin combined with cyclosporine in patients with blood transfusion dependent non-severe aplastic anemia

Recruiting
4
50
 
low-dose ;high-dose
Jiangsu Province Hospital; Jiangsu Province Hospital, Self support
Blood transfusion dependent non-severe aplastic anemia
 
 
NCT06009497: Romiplostim in Combination With CsA vs. CsA in the Treatment of Newly Diagnosed NSAA

Not yet recruiting
4
44
RoW
Romiplostim, Ciclosporin
Peking Union Medical College Hospital
Non Severe Aplastic Anemia
12/24
12/25
ChiCTR2100045895: Clinical database registration of aplastic anemia patients

Recruiting
4
450
 
ciclosporin ;CsA combined with hematopoietic therapy ;Intensive immunosuppressive therapy ;Hematopoietic stem cell transplantation ;Promoting hematopoiesis therapy
Jiangsu Province Hospital; The First Affiliated Hospital of Nanjing Medical University Jiangsu Province Hospital, Self support
aplastic anemia
 
 
NCT05996393: CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly

Not yet recruiting
4
60
RoW
Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit
Peking Union Medical College Hospital
Aplastic Anemia
10/25
10/26
ChiCTR2000041485: Efficacy of Danazol after no response to cyclosporin in transfusion independent aplastic anemia: a prospective study

Recruiting
4
228
 
Cyclosporine combined with danazol ;Cyclosporine
Institute of Hematology & Hospital of Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College; Institute of Hematology & Hospital of Blood Diseases, Chinese Academy of Medical Sciences, self-raised
transfusion independent aplastic anemia
 
 
ChiCTR2200056659: Allopurinol in the treatment of cyclosporine-induced hyperuricemia in children with aplastic anemia:a randomized controlled study

Not yet recruiting
4
40
 
Receive allopurinol tablets ;Receive placebo
The Seventh Affiliated Hospital, Sun Yat-sen University; The Seventh Affiliated Hospital, Sun Yat-sen University, The Seventh Affiliated Hospital, Sun Yat-sen University Clinical Research 735 Program”
hyperuricemia
 
 
NCT05057468: Second-line Treatment of Primary Autoimmune Hemolytic Anemia

Recruiting
3
30
RoW
Cyclosporine, Rituximab
Assiut University
Primary Autoimmune Hemolytic Anemia
11/22
11/22
TransIT, NCT05600426: A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (, BMT CTN 2202)

Recruiting
3
234
US
cyclosporine, Matched Unrelated Donor Hematopoetic Stem Cell Transplant, horse anti-thymocyte globulin (ATG), ATGAM, rabbit anti-thymocyte globulin (ATG), thymoglobulin, Methotrexate, Fludarabine, Cyclophosphamide, low-dose total body irradiation (TBI), Immunosuppressive Therapy (IST)
Boston Children's Hospital, Center for International Blood and Marrow Transplant Research, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), North American Pediatric Aplastic Anemia Consortium, Pediatric Transplantation and Cellular Therapy Consortium, Blood and Marrow Transplant Clinical Trials Network
Severe Aplastic Anemia
12/29
12/29
ChiCTR1900028153: A Multi-centre Clinical Study of Pai-Neng-Da Capsule in the Treatment of Chronic Aplastic Anemia

Completed
2/3
100
 
Pai-Neng-Da Capsule + Testosterone undecanoate capsule (80mg / day), cyclosporine capsule (3-7mg / kg. D) ;Testosterone undecanoate capsule (80mg / day), cyclosporine capsule (3-7mg / kg. D)
Jinhua people's Hospital; None, Project of Zhejiang Province TCM Science Research Fund in 2015
Aplstic Anemia
 
 
ChiCTR2100043229: A Single-Center, Single-Arm, Phase II Clinical Study of the Efficacy and Safety of Cyclosporine Combined with Eltrombopag Olamine Tablets in Treatment-Naive Transfusion-Dependent Non-Severe Aplastic Anemia

Recruiting
2
61
 
Elrombopag combined with Cyclosporine
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Beijing Novartis Pharma Co., Ltd.
Aplastic anemia
 
 
NCT04304820: Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

Recruiting
2
39
US
Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin
National Heart, Lung, and Blood Institute (NHLBI)
Severe Aplastic Anemia
03/25
05/28
NCT05797623: Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Treatment of Non-severe Aplastic Anemia

Recruiting
2
78
RoW
Trappa ethanolamine tablets ; ciclosporin, Placebo ; ciclosporin
Jiangsu HengRui Medicine Co., Ltd.
Non-severe Aplastic Anemia
05/24
05/25
NCT06004752: Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly

Recruiting
2
30
RoW
Ciclosporin, Avatrombopag
Peking Union Medical College Hospital
Aplastic Anemia
08/24
08/25
NCT00357565: Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia

Active, not recruiting
2
33
US
filgrastim, G-CSF, busulfan, Busulfex, cyclosporine, CSA, fludarabine phosphate, Fludara, melphalan, Alkeran, mycophenolate mofetil, MMF, umbilical cord blood transplantation
Masonic Cancer Center, University of Minnesota
Leukemia, Myelodysplastic Syndromes, Childhood Acute Myeloid Leukemia in Remission, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Previously Treated Myelodysplastic Syndrome, Secondary Myelodysplastic Syndrome, Refractory Anemia With Excess Blasts in Transformation, Refractory Anemia With Excess Blasts, Refractory Anemia, De Novo Myelodysplastic Syndrome, Childhood Myelodysplastic Syndrome
06/24
12/25
NCT01623167: Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

Recruiting
1/2
207
US
Cohort 1: hATG, CsA, EPAG Day 14 to Month 6, Horse Antithymocyte Globulin, Cyclosporine, Promacta, Eltrombopag, Cohort 2: hATG, CsA, EPAG Day 14 to Month 3, Cohort 3: hATG, CsA (dose reduced), EPAG day 1 to month 6, Extension Cohort, Horse Antithymocyte Globulin (hATG), Cyclosporine (CsA), Promacta, Eltrombopag (EPAG)
National Heart, Lung, and Blood Institute (NHLBI), Novartis
Severe Aplastic Anemia
01/18
01/29
ChiCTR-IPR-14005720: A single center, Randomized controlled, opened clinical reserch for evaluating the effectiveness of recombinant human thrombopoietin combined with immunosuppressive therapy in the treatment of newly diagnosed acquired severe aplastic anemia

Recruiting
1
172
 
rTPO ;Ciclosporine
Blood Diseases Hospital, Chinese Academy of Medical Sciences; Level of the institution:, Nil
severe aplastic anemia
 
 
ChiCTR-IOR-17011653: A prospective, randomized, controlled clinical study of non transfusion dependent non severe aplastic anemia treated with cyclosporine, androgen and levamisole hydrochloride

Not yet recruiting
N/A
248
 
none ;levamisole hydrochloride
The First affiliated Hospital of Zhejiang Chinese Medical University; The First affiliated Hospital of Zhejiang Chinese Medical University, raise independently
Aplastic anemia
 
 
ChiCTR1900023476: Multicenter, prospective and open clinical study for rapamycin in the treatment of autoimmune hemolytic anemia

Not yet recruiting
N/A
80
 
glucocorticoid ;glucocorticoid & Ciclosporin ;glucocorticoid & rapamycin ;rapamycin
Tianjin Medical University General Hospital; Tianjin Medical University General Hospital, Clinical Founding
Autoimmune
 
 
ChiCTR-IOR-16008738: A single center, randomized, controlled, opened label study for evaluating Cyclosporin alone or combined with Stanozolol in the treatment of aplastic anemia

Recruiting
N/A
200
 
Cyclosporin ;Cyclosporin and Stanozolol
The First Affiliated Hospital of Zhengzhou University; The First Affiliated Hospital of Zhengzhou University, The First Affiliated Hospital of Zhengzhou University Dr.Scientific Research Foundation
aplastic anemia
 
 
ChiCTR1800019487: A clinical study for different infusion methods of mesenchymal stem cells in the treatment of aplastic anemia

Recruiting
N/A
60
 
Treatment regimen of ATG combined with cyclosporin immunosuppression ;MSCs+Treatment regimen of ATG combined with cyclosporin immunosuppression
Jiangmen Central Hospital; Jiangmen Central Hospital, Wu Jieping medical association foundation
Aplastic anemia
 
 
ChiCTR2000038744: To explore the intervention effect of Xiaoyu Xiezhuo Yin on chronic cyclosporin nephropathy in patients with aplastic anemia based on autophagy and ACE2-Ang(1-7)-Mas axis

Not yet recruiting
N/A
60
 
none ;none ;Conventional treatment ;Conventional treatment+traditional Chinese medicine
The First Affiliated Hospital of ZheJiang Chinese Medical University; The First Affiliated Hospital of ZheJiang Chinese Medical University, Self-funded
Chronic cyclosporine nephropathy
 
 
ChiCTR1900027553: Clinical therapies for patients in subtypes of non-severe aplastic anemia

Not yet recruiting
N/A
490
 
Cyclosporine ;Cyclosporine ;Cyclosporine+Danazol ;CSA+TPO+G-CSF
Institute of Hematology & Hospital of Blood Diseases, Chinese Academy of Medical Sciences; Institute of Hematology & Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin Major Disease Prevention and Control Science and Technology Project
non-severe aplastic anemia
 
 
NCT05571332: Efficacy and Safety of Avatrombopag Combined With IST for the Treatment of HAAA and SAA With Abnormal Liver Function

Recruiting
N/A
39
RoW
Avatrombopag 20 MG Oral Tablet, porcine ATG, Cyclosporine(CsA)
Institute of Hematology & Blood Diseases Hospital
Aplastic Anemia
12/23
06/24
NCT02845596: Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia

Active, not recruiting
N/A
40
US
cyclosporine, Matched Unrelated Donor Hematopoietic Stem Cell Transplant, horse anti-thymocyte globulin (ATG), ATGAM, rabbit anti-thymocyte globulin (ATG), Thymoglobulin, methotrexate, fludarabine, cyclophosphamide, low-dose total body irradiation (TBI), Immunosuppressive Therapy (IST)
Michael Pulsipher, MD
Severe Aplastic Anemia
04/24
04/24

Download Options